109 related articles for article (PubMed ID: 23200910)
21. Diagnostic performance of HPV E6/E7 mRNA testing towards HPV-DNA testing and p16/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions.
Carcea F; Vavoulidis E; Petousis S; Papandreou P; Siarkou CM; Nasioutziki M; Papanikolaou A; Dinas K; Daniilidis A
J Obstet Gynaecol Res; 2021 Oct; 47(10):3607-3617. PubMed ID: 34374179
[TBL] [Abstract][Full Text] [Related]
22. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy.
Dijkstra MG; van Niekerk D; Rijkaart DC; van Kemenade FJ; Heideman DA; Snijders PJ; Meijer CJ; Berkhof J
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):55-63. PubMed ID: 23733907
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
24. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
Donà MG; Vocaturo A; Giuliani M; Ronchetti L; Rollo F; Pescarmona E; Carosi M; Vocaturo G; Benevolo M
Gynecol Oncol; 2012 Aug; 126(2):198-202. PubMed ID: 22588180
[TBL] [Abstract][Full Text] [Related]
25. Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study.
Gilbert L; Ratnam S; Jang D; Alaghehbandan R; Schell M; Needle R; Ecobichon-Morris A; Wadhawan A; Costescu D; Elit L; Wang P; Zahariadis G; Chernesky M
Cancer Biomark; 2022; 34(3):347-358. PubMed ID: 35001877
[TBL] [Abstract][Full Text] [Related]
26. Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing.
Sørbye SW; Fismen S; Gutteberg T; Mortensen ES
PLoS One; 2010 Sep; 5(9):e12724. PubMed ID: 20856930
[TBL] [Abstract][Full Text] [Related]
27. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
28. Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.
Zappacosta R; Colasante A; Viola P; D'Antuono T; Lattanzio G; Capanna S; Gatta DM; Rosini S
Biomed Res Int; 2013; 2013():453606. PubMed ID: 24369532
[TBL] [Abstract][Full Text] [Related]
29. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.
Granados R; Tellez-Safina H; Solis I; Mateos F; Rodriguez-Barbero JM; Aramburu JA; Huertas MA; Bajo P; Camarmo E; Corrales T; Medina P; Calvo B; Martin E; Anta L; Zamora M; Alcaide T
Diagn Cytopathol; 2017 Dec; 45(12):1065-1072. PubMed ID: 28949442
[TBL] [Abstract][Full Text] [Related]
31. Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.
Giorgi Rossi P; Bisanzi S; Allia E; Mongia A; Carozzi F; Gillio-Tos A; De Marco L; Ronco G; Gustinucci D; Del Mistro A; Frayle H; Iossa A; Fantacci G; Pompeo G; Cesarini E; Bulletti S; Passamonti B; Rizzi M; Penon MG; Barca A; Benevolo M
J Clin Microbiol; 2017 Apr; 55(4):1056-1065. PubMed ID: 28100595
[TBL] [Abstract][Full Text] [Related]
32. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Halfon P; Ruiz F; Smith JS
Int J Cancer; 2011 Aug; 129(3):691-701. PubMed ID: 20941740
[TBL] [Abstract][Full Text] [Related]
34. Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia.
Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
J Clin Microbiol; 2011 Nov; 49(11):3794-9. PubMed ID: 21940473
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implication of high risk human papillomavirus E6 and E7 mRNA in patients with intraepithelial lesions of the cervix in relationship to age.
Frega A; Lorenzon L; Giovagnoli MR; De Sanctis L; Fabiano V; Lukic A; Moscarini M; Torrisi MR; French D
Int J Immunopathol Pharmacol; 2011; 24(2):461-70. PubMed ID: 21658320
[TBL] [Abstract][Full Text] [Related]
37. Role of E6/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system.
Zappacosta R; Gatta DM; Marinucci P; Capanna S; Lattanzio G; Caraceni D; Rosini S
Expert Rev Mol Diagn; 2015 Jan; 15(1):137-50. PubMed ID: 25245757
[TBL] [Abstract][Full Text] [Related]
38. The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
Magkana M; Mentzelopoulou P; Magkana E; Pampanos A; Daskalakis G; Domali E; Rodolakis A; Pappa K
PLoS One; 2021; 16(6):e0253045. PubMed ID: 34115809
[TBL] [Abstract][Full Text] [Related]
39. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the performance of algorithms for cervical cancer screening: evidence from the Ludwig-McGill cohort study.
Chevarie-Davis M; Ramanakumar AV; Ferenczy A; Villa LL; Franco EL;
Gynecol Oncol; 2013 Mar; 128(3):415-9. PubMed ID: 23234804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]